Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 468520, 13 pages
http://dx.doi.org/10.1155/2015/468520
Review Article

Xuezhikang Capsule for Type 2 Diabetes with Hyperlipemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trails

1Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beixiange 5, Xicheng District, Beijing 100053, China
2Beijing University of Chinese Medicine, Beijing 100029, China
3Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China

Received 26 March 2015; Revised 28 May 2015; Accepted 4 June 2015

Academic Editor: Mariangela Rondanelli

Copyright © 2015 Min Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Zhong, “The epidemiological study of type 2 diabetes mellitus,” Guide of China Medicine, no. 13, pp. 124–125, 2011. View at Google Scholar
  2. W. Xin, “The effect of arterial stiffness index for Xuzhikang Capsule in patients with type 2 diabetes,” Chinese Journal of Modern Drug Application, vol. 9, no. 2, pp. 127–128, 2015. View at Google Scholar
  3. J. I. Barzilay, C. F. Spiekerman, L. H. Kuller et al., “Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the cardiovascular health study,” Diabetes Care, vol. 24, no. 7, pp. 1233–1239, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Chen, J. Ning, and J. Wang, “The effect of atorvastatin on lipid metabolism in diabetic patients,” Chinese Journal of Aesthetic Medicine, vol. 19, no. 4, pp. 215–216, 2010. View at Google Scholar
  5. L. Le and J. Liu, “The analysis of adverse reaction and prevention countermeasures of statins,” Modern Practical Medicine, vol. 26, no. 9, pp. 1166–1168, 2014. View at Google Scholar
  6. Y. Li, Z. Jia, L. Jiang et al., “Xuezhikang capsule for curative effect in patients with coronary heart disease (CHD) combined hyperlipidemia: meta-analysis,” Chinese Journal of Evidence-Based Cardiovascular Medicine, vol. 6, no. 1, pp. 25–29, 2014. View at Google Scholar
  7. Y. Liao and N. Chen, “The observation of curative effect of Xuezhikang capsule with simvastatin for type 2 diabetic hyperlipemia,” National Medical Frontiers of China, vol. 5, no. 21, pp. 44–45, 2010. View at Google Scholar
  8. Y. Liu and W. Dong, “Effect of Xuezhikang and simvastatin on hypedipemia of non-insulin dependent diabete,” Hainan Medical Journal, vol. 19, no. 1, pp. 3–4, 2008. View at Google Scholar
  9. G. Wang, Y. Luo, and H. Ren, “The observation of curative effect of Xuezhikang capsule for type 2 diabetic hyperlipemia,” Chinese Journal of Hospital Pharmacy, vol. 25, no. 12, pp. 1160–1161, 2005. View at Google Scholar
  10. L. Lanfan and D. Zurong, “The observation of curative effect of Xuezhikang capsule for type 2 diabetic hyperlipemia,” Chinese Journal of Misdiagnostics, vol. 5, no. 2, pp. 293–294, 2005. View at Google Scholar
  11. Y. Tong, “The experience of diagnosis and treatment of 46 cases of type 2 diabetes mellitus associated with dyslipidemia,” China Foreign Medical Treatment, no. 2, pp. 25–27, 2012. View at Google Scholar
  12. W. Zhe, “The observation of curative effect of Xuezhikang capsule with atorvastatin for diabetic hyperlipemia,” Chinese and Foreign Medical Research, vol. 10, no. 21, pp. 16–17, 2012. View at Google Scholar
  13. C. Xueling, “The observation of curative effect of Xuezhikang capsule with fluvastatin for type 2 diabetic hyperlipemia,” Modern Journal of Integrated Traditional Chinese with Western Medicine, vol. 16, no. 32, p. 4801, 2007. View at Google Scholar
  14. G. Chen, “The observation of curative effect of Xuezhikang capsule with fluvastatin for type 2 diabetic hyperlipemia,” Chinese Journal of Modern Drug Application, vol. 7, no. 19, pp. 142–144, 2013. View at Google Scholar
  15. Y. Yang, “The observation of curative effect of Xuezhikang capsule for type 2 diabetic hyperlipemia,” Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 17, no. 11, pp. 1646–1647, 2008. View at Google Scholar
  16. L. Jianhui, “The observation of curative effect of Xuezhikang capsule with rosuvastatin calcium for type 2 diabetic hyperlipemia,” Asia Pacific Traditional Medicine, vol. 9, no. 4, pp. 162–163, 2013. View at Google Scholar
  17. Z. Hui and Z. Zhaoliang, “Comparison of effects between Xuezhikang and simvastatin on type 2 DM with dyslipidosis,” Journal of Medical Forum, vol. 26, no. 21, pp. 10–11, 2005. View at Google Scholar
  18. Z. Tang and X. Weng, “The observation of curative effect of Xuezhikang capsule for diabetic hyperlipemia,” China Synthesis Medicine, vol. 3, no. 7, pp. 44–45, 2002. View at Google Scholar
  19. S. Zhang and W. Chen, “The observation of curative effect of Xuezhikang capsule for elderly diabetic hyperlipemia,” China Practical Medicine, vol. 5, no. 20, pp. 149–150, 2010. View at Google Scholar
  20. Z. Yang, X. Wang, and P. Zhou, “The effect of Xuezhikang capsule for type 2 diabetic patient of blood pressure, blood fat, blood coagulation and fibrinolytic function,” Modern Journal of Integrated Traditional Chinese with Western Medicine, vol. 3, no. 10, pp. 1063–1066, 2013. View at Google Scholar
  21. T. Tongcui and L. Bihui, “Effect of Xuezhikang on glucose metabolism of type 2 diabetes mellitus,” Modern Journal of Integrated Traditional Chinese with Western Medicine, vol. 11, no. 3, pp. 190–192, 2002. View at Google Scholar
  22. Y. Lin, J. Zuo, H. Wang et al., “The observation of curative effect of Xuezhikang capsule for 80 cases of type 2 diabetic hyperlipemia,” Chinese Journal of Gerontology, vol. 20, pp. 243–244, 2000. View at Google Scholar
  23. W. Chen, J. Yang, and G. Ma, “The observation of curative effect of Xuezhikang capsule for diabetic hyperlipemia,” West China Journal of Pharmaceutical Sciences, vol. 15, no. 2, p. 146, 2000. View at Google Scholar
  24. F. Chen, “The observation of curative effect of Xuezhikang capsule for type 2 diabetic hyperlipemia,” Modern Journal of Integrated Traditional Chinese with Western Medicine, vol. 13, no. 19, pp. 2548–2549, 2004. View at Google Scholar
  25. X. Hao, “The comparison of curative effect of Xuezhikang capsule with Duoxikang for type 2 diabetic hyperlipemia,” Occupation and Health, vol. 15, no. 8, pp. 116–117, 2002. View at Google Scholar
  26. Y. Ke, “The efficacy and safety of atorvastatin in treatment of hyperlipidemia,” Chinese Journal of Cardiology, vol. 29, no. 3, pp. 132–135, 2001. View at Google Scholar
  27. W. Guo and S. Guo, “The relationship between insulin resistance in type 2 diabetes and hyperlipidemia as well as microvascular lesions,” Chinese Journal of Misdiagnosis, vol. 4, no. 3, p. 346, 2004. View at Google Scholar
  28. R. Yue, G. Gong, and Y. Li, “The traditional Chinese ideas discussed of diabetes,” Chinese Journal of Information on TCM, vol. 15, no. 10, pp. 85–86, 2008. View at Google Scholar
  29. L. Wang, S. Liang, and X. Feng, “The effect of Xuezhikang capsule for type 2 diabetic hyperlipemia about blood lipids and blood glucose metabolism,” Practical Cardio-Cerebral Pulmonary Vascular Disease, vol. 15, no. 10, pp. 85–86, 2008. View at Google Scholar